Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $1.5 million.

  • Jaguar Health's Shares Outstanding (Weighted Average) rose 30372.41% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 30372.41%. This contributed to the annual value of $294534.0 for FY2024, which is 180995.4% up from last year.
  • Per Jaguar Health's latest filing, its Shares Outstanding (Weighted Average) stood at $1.5 million for Q3 2025, which was up 30372.41% from $1.0 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Shares Outstanding (Weighted Average) ranged from a high of $45.8 million in Q3 2021 and a low of $15421.0 during Q4 2023
  • Over the past 5 years, Jaguar Health's median Shares Outstanding (Weighted Average) value was $1.0 million (recorded in 2025), while the average stood at $8.0 million.
  • As far as peak fluctuations go, Jaguar Health's Shares Outstanding (Weighted Average) crashed by 9882.42% in 2023, and later surged by 180995.4% in 2024.
  • Over the past 5 years, Jaguar Health's Shares Outstanding (Weighted Average) (Quarter) stood at $596154.0 in 2021, then surged by 120.0% to $1.3 million in 2022, then tumbled by 98.82% to $15421.0 in 2023, then skyrocketed by 1809.95% to $294534.0 in 2024, then skyrocketed by 413.75% to $1.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $1.5 million for Q3 2025, versus $1.0 million for Q2 2025 and $626644.0 for Q1 2025.